National Institutes of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Funding Opportunity Title
NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research (U54)
U54 Specialized Center- Cooperative Agreements
Funding Opportunity Announcement (FOA) Number
Companion Funding Opportunity
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)
Funding Opportunity Purpose
The National Institute on Minority Health and Health Disparities (NIMHD) seeks to establish specialized Transdisciplinary Collaborative Centers for Health Disparities Research (TCC) that support trans-disciplinary coalitions of academic institutions, community organizations, service providers and systems, government agencies and other stakeholders focused on priority areas in minority health and health disparities. This initiative will support transdisciplinary targeted research, implementation and dissemination activities that transcend customary approaches and “silo” organizational structures to address critical questions at multiple levels in innovative ways. The purpose of this funding opportunity is to support the development of TCCs focused on health policy research and social determinants of health research.
July 6, 2012
Letter of Intent Due Date
August 4, 2012
Application Due Date(s)
September 4, 2012
AIDS Application Due Date(s)
Scientific Merit Review
Advisory Council Review
Earliest Start Date(s)
September 5, 2012
Due Dates for E.O. 12372
Required Application Instructions
It is critical that applicants follow the instructions in the PHS398 Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. While some links are provided, applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
Improving minority health and eliminating health disparities requires a trans-disciplinary framework that cuts across organizational silos and fosters an integrated approach across multiple disciplines– biology, behavioral and social sciences, environmental science, public health, health care, economics, public policy and many other disciplines. It also requires strong collaborations between researchers and community organizations, service providers and systems, government agencies and other stakeholders to ensure that contextually appropriate and relevant research is conducted and that findings can translate into sustainable individual-, community- and systems-level changes that improve population health.
Collaboration at the regional level is particularly important and timely because it provides opportunities for institutions and organizations to achieve a broader reach than is possible with isolated local efforts while combining expertise and resources in an era of constrained budgets. At the same time, it fosters applied research that is uniquely responsive to specific population-based, environmental, sociocultural, and political factors that influence health within a particular region.
In recognition of these opportunities, the National Institute on Minority Health and Health Disparities (NIMHD) seeks to establish Transdisciplinary Collaborative Centers for Health Disparities Research (TCC) specialized in one of several priority research areas in minority health and health disparities. The concept of regional collaborative centers is structured around an overarching goal delineated in the NIH Health Disparities Strategic Plan 2009-2013, integrating research, capacity building and outreach/dissemination to (1) develop a coordinated interdisciplinary approach to reduce and ultimately eliminate health disparities; and (2) develop opportunities to leverage resources and enhance collaboration.
TCCs will support partnerships and collaborations between a broad range of stakeholders to develop a uniquely transformative and novel infrastructure for conducting targeted research, implementation and dissemination activities. It is expected that the transdisciplinary collaborative teams established under the proposed TCC will develop new and integrative ways for exploring the many complex interactions that influence minority health and health disparities within a defined region, and will use the knowledge gained to produce sustainable change within the region and beyond.
This funding opportunity will support TCCs focused on health policy research and social determinants of health research. Future TCC funding opportunities will target additional priority research areas.
Public and private-sector policies and practices have great potential to influence minority health and health disparities, in both positive and negative directions. Research advances that identify successful strategies to reduce health disparities are unlikely to have a sustained or widespread impact unless they can directly inform and shape policy and practice. At the same time, the impact of new or existing policies on minority health and health disparities may not be evident in the absence of rigorous research evaluation. Research topics of specific interest include but are not limited to:
The importance of social, cultural, and environmental factors in driving or sustaining health disparities is increasingly recognized. The World Health Organization identifies the social determinants of health as the circumstances in which people are born, grow up, live, work and age, and the systems put in place to deal with illness. These circumstances are in turn shaped by wider forces, including economics, social policies, politics and other forces operating at many levels. More work is needed to understand how all of these interconnecting factors and forces can be addressed in an integrated way to achieve meaningful and lasting changes in health and health behavior at the individual and community level. Activities that address social determinants of health for multiple health disparity populations within a region are strongly encouraged. Research topics of specific interest include but are not limited to:
Applicants must describe the region on which they will focus (examples include but are not limited to rural counties in a tri-state area, states served by a particular Level 1 Trauma Center, counties or states impacted by a particular natural disaster, adjoining states with large indigenous populations, etc.) and a justification for the proposed regional focus. Although delineation of the region and populations(s) involved is determined by the applicant, applicants must specify in which of the 10 established HHS regions (http://www.hhs.gov/about/regions/) their work will occur. Applicant-defined regions of focus may fall within a single HHS region or across multiple regions.
REGION I: CT, ME, MA, NH, RI, VT
REGION II: NJ, NY, PR, VI
REGION III: DE, D.C., MD, PA, VA, WV
REGION IV: KY, MS NC, TN, AL, FL, GA, SC
REGION V: IL, IN, MI, MN, OH, WI
REGION VI: AR, LA, NM, OK, TX
REGION VII: IA, KS, MO, NE
REGION VIII: CO, MT, ND, SD, UT, WY
REGION IX: AZ, CA, HI, NV, and the six U.S. Associated Pacific jurisdictions
REGION X: AK, ID, OR, WA
Applications must identify collaborating partners within and across the proposed region to engage a broad range of stakeholders in TCC activities and promote optimal use of TCC resources. Applicants are strongly encouraged to identify and work with NIMHD grantees in their respective regions that have expertise and/or interest in health policy research or social determinants of health research or other relevant resources that could be leveraged to facilitate achievement of TCC goals and objectives. Along the same lines, TCCs are encouraged to collaborate with other federally-funded investigators within and outside the Center’s region as appropriate to achieve efficiencies while advancing the aims of the center.
To ensure that TCCs contribute optimally and effectively to national minority health and health disparities research efforts, the overall direction and scope of activities supported by this initiative will be coordinated and monitored by an TCC Program Coordinating Committee consisting of TCC PIs/PDs and NIMHD program staff. The TCC Program Coordinating Committee will meet at least annually to assess progress toward program goals and promote information exchange across regions.
Application Types Allowed
The OER Glossary and the PHS398 Application Guide provide details on these application types.
Funds Available and Anticipated Number of Awards
NIMHD intends to commit $3,000,000 in FY 2012.
Application budgets are limited to $1,500,000 in total costs during the planning phase and $3,000,000 per year in total costs during the implementation phase.
Award Project Period
The award project period is five years.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Eligible applicant institutions may not submit more than one application as the sole or lead institution. If more than one application is received identifying the same institution as the sole applicant or as the lead applicant in a partnership or consortium, all applications from this institution may be returned without review. There are no limitations on the number of inter-institutional partnerships an institution may establish. An applicant may be the lead institution on one application and be a non-leading partner or consortium member on another.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are
not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant organizations must complete the following registrations as described in the PHS398 Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.
All Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.
All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least4-6 weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
For institutions/organizations proposing multiple PD(s)/PI(s), visit the Multiple Program Director(s)/Principal Investigator(s) Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the PHS398 Application Guide.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Only one application will be accepted per applicant organization. For institutions of higher education, separate institutions for purposes of this FOA are entities governed by different Chancellors or Presidents.
NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application.
Applicants are required to prepare applications according to the current PHS 398 application forms in accordance with the PHS 398 Application Guide.
It is critical that applicants follow the instructions in the PHS398 Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Robert Nettey, MD
Office of Extramural Research Administration
National Institute on Minority Health and Health Disparities (NIMHD)
6707 Democracy Boulevard, Suite 800
Bethesda, MD 20892
Applications must be prepared using the PHS 398 research
grant application forms and instructions for preparing a research grant
application. Submit a signed, typewritten original of the application,
including the checklist, and three signed photocopies in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)
At the time of submission, two additional paper copies of
the application and all copies of the Appendix files must be sent to:
Robert Nettey, MD
Office of Extramural Research Administration
National Institute on Minority Health and Health Disparities (NIMHD)
6707 Democracy Boulevard, Suite 800
Bethesda, MD 20892
All page limitations described in the PHS398 Application Guide and the Table of Page Limits must be followed, with the following requirements for this multi-component application:
Administrative Core and Management Plan- 6 pages
Collaborations and Partnerships- 12 pages
Research Core- 6 pages
Collaborative Research Projects-12 pages per project
Technical Components - 6 pages
Pilot Project Program- 6 pages
All instructions in the PHS398 Application Guide must be followed, with the following additional instructions:
The Research Plan section must include the eight components listed below. Components 2-7 each must have a corresponding itemized budget and narrative budget justification.
1. Program Overview (12 pages)
Each TCC must structure its activities around one of the two designated themes, health policy research or social determinants of health research. The proposed theme, overall goals and specific aims should be developed prior to submission and must be specified in the application. Delineate the geographic region to be covered, including the HHS region(s) where work will occur, and identify participating consortium institutions/organizations and describe their respective roles and contributions. Describe key short- and long-term goals for the proposed TCC and explain the scientific rationale for selecting the region, consortium partners and population(s) to be included.
Summarize the strengths of the proposed consortium, including participants’ relevant expertise in the chosen research area as well as experience participating in productive regional collaborations and partnerships. Describe institutional commitment and organizational capabilities for regional coordination and collaboration, particularly with community-based organizations, federal, state, and local agencies as well as academic and private sector partners. Also describe any shared core facilities and other research resources available. Applicant organizations that currently hold federally-funded center grants should describe center expertise and resources available to support the proposed regional activities, as well as how TCC activities are distinct from those of the existing center.
Describe plans and timelines for accomplishing the following objectives during the planning phase: a) solidify collaborative relationships with all individual and institutional/organizations partners to create a regional framework that will support the proposed research, implementation and dissemination activities; b) fully assess existing research and outreach/dissemination capacity for the specified area of emphasis, as well as scientific and administrative resources and needs; c) identify and engage additional partners needed to fill identified gaps; d) finalize procedures for soliciting, selecting and overseeing pilot research projects; and e) develop a detailed plan and timelines for the program implementation phase.
2. Administrative Core and Management Plan (6 pages)
The Administrative Core will manage, coordinate and supervise the entire range of proposed TCC activities, monitor progress and ensure that component plans are implemented. Clearly describe how this will be achieved and explain the roles and responsibilities of Administrative Core personnel. A PD/PI must serve as Administrative Core director and commit at least three person months to this position, in addition to any involvement in other TCC activities. Each TCC should also have a Program Director with similar qualifications who can act for the PD(s)/PI(s) should the need arise. The Administrative Core director is responsible for ensuring that TCC-supported research is carried out in compliance with applicable federal regulations and policies.
Include a Management Plan describing the TCC’s organizational and governance structure. Describe the composition and roles of any committees proposed to help manage TCC activities. Each TCC must have a Consortium Steering Committee composed of the PD(s)/PI(s), one or more members representing consortium partner organizations, two external members selected by the PD(s)/PI(s), NIMHD Program Official, and NIMHD Project Scientists. The Consortium Steering Committee will oversee the management and direction of the TCC and each major TCC component. Describe the allocation and prioritization of fiscal and other resources, and procedures for ensuring timely and effective communication between TCC participants.
3. Collaborations and Partnerships Plan (12 Pages, total)
Describe how the TCC will serve as a regional focal point to organize and nurture productive working relationships with a broad cross-section of community organizations, minority and health disparity populations, health care provider organizations, for-profit or non-profit organizations and foundations, and other stakeholders. Include details on strategies and procedures for identifying partners and engaging in formal relationships, e.g., through Memoranda of Understanding and/or other mutual agreements, as well as assessing the effectiveness of those relationships on an ongoing basis and resolving disputes or misunderstandings. Also describe specific opportunities to establish or strengthen associations with federal agencies such as the Centers for Disease Control and Prevention (CDC), AHRQ, HRSA, SAMHSA, EPA, USDA, etc.; with state and local health departments and other relevant agencies with expertise and/or interest in the proposed research, implementation and dissemination activities.
Applicants are strongly encouraged to identify and work with NIMHD grantees in their respective regions who have expertise and/or interest in areas related to health policy research or social determinants of health research or other relevant resources that could be leveraged to facilitate achievement of TCC goals and objectives and avoid unnecessary duplication. Along the same lines, TCC researchers are encouraged to collaborate with other federally-funded investigators within and outside the Center’s region as appropriate to achieve efficiencies while advancing the aims of the center.
4. Research Core (6 pages)
Each TCC will establish and support a collaborative research program consisting of regional research sub-projects that are likely to significantly advance understanding of how health policies and practices or the social determinants of health influence the health and well-being of communities and populations within a defined region. Provide in this section an overview of the regional collaborative research program, including over-arching goals, objectives and specific aims. Do not describe individual research sub-projects. Include a budget and narrative budget justification for this core in the application’s budget section.
Describe the process used by TCC organizers to select the proposed projects, as well as procedures to monitor and assess progress. It is expected that under-performing projects will be discontinued and replaced by new projects with greater potential as the program evolves and matures.
4.1. Collaborative Research Sub-Projects (12 pages per project)
TCC applications must include descriptions (using PHS 398 format) of 2-4 regional collaborative research sub-projects. Each sub-project must address a significant problem within the chosen TCC theme, be regional in scope, and be conducted by a team of investigators that includes members of consortium partner organizations. The research team can include senior and junior faculty, post-doctoral or other trainees, as well as community members, all with the appropriate justification, including roles and responsibilities of all members of the research team. Each project will be reviewed on its own merits. Expected improvements in health relative to an existing baseline measure for the health disparity population(s) under study should be provided when possible. Include a budget and narrative budget justification for each sub-project in the application’s budget section.
4.2. Technical Components (6 pages per core)
Applicants may propose shared cores to help support research projects. Examples include but are not limited to biospecimen repositories, regional data warehouses, biostatistics/study design core, bioethics and regulatory knowledge core, etc. Explain how each core will serve the proposed research projects, the role it core will play in the overall research plan, and its value added to the TCC and the region as a whole. Describe plans for ensuring equitable access to core resources for all TCC participants, along with plans for staffing, managing, and prioritizing core utilization and charging user fees (if any). Include a budget and narrative budget justification for each core in the application’s budget section.
TCC awards will not support institutional cores that duplicate resources supported by other federal funding if those resources are already available for use by TCC participants. Cores whose sole mission is to support clinical research activities will not be supported; clinical research, where appropriate, will be supported as collaborative research projects.
5. Pilot Project Program (6 pages)
The purpose of the pilot project program is to further encourage and sustain active participation of TCC partners in the full range of TCC research, implementation and dissemination efforts by providing sub-awards to consortium partner organizations. TCC pilot projects can provide a means to seed emerging research areas, explore new methodologies or approaches for basic and/or applied research, and pursue new regional partnerships and collaborations that could evolve into independently funded research and/or demonstration projects. The Administrative Core is responsible for managing the Pilot Project Program.
Describe the overall scope, including expected number of projects to be supported each year; eligibility requirements; solicitation, submission, review, and selection criteria and processes; procedures for program oversight and evaluation; limits on dollars available and number of years of support per project; and plans for ensuring that projects selected for support will comply fully with applicable Federal policies, rules, and guidelines for research involving human subjects. Also describe the support and resources in place to ensure sound research design, including appropriate statistical analyses. Do not include detailed proposals or descriptions of specific pilot projects. Include a budget and narrative budget justification for the Pilot Project Program in the application’s budget section.
The plan for soliciting pilot projects must include provisions for mentoring when appropriate. If new and early-stage investigators (as defined by NIH) are eligible to serve as pilot project leaders, describe mentoring activities to be provided during the pilot project planning, execution, and post-completion phases; how mentors for such investigators will be selected; and how mentoring activities will be evaluated. If a suitable mentor is not available within the applicant institution, appropriate mentors may be enlisted from outside institutions.
New activities involving human subjects and vertebrate animals require NIMHD’s prior approval as described more fully in NOT-MD-08-002.
6. Implementation and Dissemination Plan (6 pages)
Provide a detailed plan regarding steps to disseminate research findings to collaborators, communities, service providers, and policy makers in the region. Dissemination plans based primarily on scientific manuscripts and conference presentations are not sufficient. The plan should include the following elements:
7. Evaluation Plan (6 pages, total)
Provide a comprehensive Evaluation Plan to be used to monitor the conduct and track the progress of proposed TCC research, implementation and dissemination activities. Describe how the evaluation will be conducted, the principal measures and metrics to be used, and the potential sources of data. Also include a detailed self-evaluation plan to assess achievement of short- and long-term TCC goals. The Administrative Core is responsible for implementing the Evaluation Plan.
Since the major purpose of the evaluation is to provide information to assist with TCC planning and management, the plan should address both administrative and scientific function and accomplishments. The Evaluation Plan should address the following areas of particular importance: translational activities; scope and impact of research; innovation; collaboration and communication; integration and synergy; and funds management. Describe timelines, key milestones and expected outcomes for each area as appropriate.
While evaluation should be a continuous process, a formal evaluation by an outside, independent group selected by TCC leadership and approved by NIMHD staff should be conducted at least every two years. TCCs may also be called upon to gather data and participate in the development of a national TCC Program evaluation.
Resource Sharing Plan
Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies (GWAS)) as provided in the PHS398 Application Guide.
Do not use the Appendix to circumvent page limits. Follow all instructions for the Appendix (please note all format requirements) as described in the PHS398 Application Guide.
Part I. Overview Information contains information about Key Dates.
Information on the process of receipt and determining if
your application is considered “on-time” is described in detail in the PHS398
Applicants may track the status of the application in the eRA Commons, NIH’s electronic system for grants administration.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost
principles, and other considerations described in the NIH Grants
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Applications must be received on or before the due dates in Part I. Overview Information. If an application is received after that date, it will not be reviewed.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by NIMHD, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.
Only the review criteria described below will be considered
in the review process. As part of the NIH mission,
all applications submitted to the NIH in support of biomedical and behavioral
research are evaluated for scientific and technical merit through the NIH peer
Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Does the project provide a compelling case for a regional approach to address the proposed topic of research? Is the project likely to create an inclusive and integrative regional infrastructure for conducting comprehensive minority health and health disparities research and applying the resulting knowledge in community settings to promote health equity?
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD(s)/PI(s), do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Are the training, experience, level of commitment, availability and qualifications of the PD(s)/PI(s) and key personnel of the leadership team adequate to successfully lead and manage the proposed Center? Are the administrative structure, lines of authority and plans for alternate lines of authority in the PD(s)/PI(s) absence appropriate and clear? Is documentation provided to demonstrate that the Project Leaders have the aptitude and volition to function as part of an integrated team? Are the training, qualifications, experience, and accomplishments of the Project Leaders and Core Directors appropriate, in terms of their abilities to accomplish the proposed projects and provide the proposed core services?
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Are the proposed goals of the TCC, as well as the plans to achieve those goals feasible, innovative and of high scientific/technical merit? Have Project Leaders sought to advance, extend or challenge existing paradigms, or develop new methodologies or technologies relevant to improving minority health and reducing or eliminating health disparities?
Are the overall strategy, methodology, and analyses
well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented?
If the project is in the early stages of development, will the strategy
establish feasibility and will particularly risky aspects be managed?
If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed? For projects that include translational and clinical studies, are adequate support and expertise available for the successful pursuit of the proposed work?
Are the conceptual framework, design, methods, and analyses for the aims of proposed research projects appropriate and complementary to the Center's overall theme and goals? Is an effective strategy for selecting approaches and technologies within the TCC to address the research questions evident? Have projects included a plan to take advantage of Center resources and for inclusion of the project into Center activities?
Are plans and timelines for solidifying collaborative relationships, assessing current capacity, engaging additional partners to fill identified gaps, and finalizing procedures for the pilot project program during the first year of support clearly described and feasible?
Are the plans to incorporate Research Projects and/or cores in response to emerging opportunities and to eliminate unproductive projects and/or cores appropriate, feasible, and equitable for all participating organizations?
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
Are the documented capability and interest of the proposed institution(s) to aid in regional health disparities research and community engagement efforts meritorious and feasible? If optional research cores are proposed, are their roles in the overall research plan and value added to the TCC and region clearly described and adequately justified? Are plans in place for ensuring equitable access to core facilities, adequate staffing, and appropriate management?
In addition to the above criteria, the following components of the application will be considered in the determination of the overall impact/priority score for the application. These components will not be scored individually.
Administrative Core and Management Plan
Collaboration and Partnerships
Pilot Project Program
Implementation and Dissemination Plan
Does it include suitable plans for periodic evaluations by an independent group?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact/priority score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Human Subjects Protection and Inclusion Guidelines.
Inclusion of Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact/priority score.
Applications from Foreign Organizations
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) in accordance with NIH peer review policy and procedures, using the stated review criteria. Review assignments will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Appeals of initial peer review will not be accepted for applications submitted in response to this FOA.
Applications will be assigned to the appropriate NIH Institute or Center and will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Council on Minority Health and Health Disparities. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD(s)/PI(s) will be able to access his or her Summary Statement (written critique) via the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH Grants
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee’s business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS, CCR Registration, and Transparency Act requirements as noted on the Award Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
The following special terms of award are in addition to, and
not in lieu of, otherwise applicable U.S. Office of Management and Budget (OMB)
administrative guidelines, U.S. Department of Health and Human Services (DHHS)
grant administration regulations at 45 CFR Parts 74 and 92 (Part 92 is
applicable when State and local Governments are eligible to apply), and other
HHS, PHS, and NIH grant administration policies.
The administrative and funding instrument used for this program will be the cooperative agreement, an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH programmatic involvement with the awardees is anticipated during the performance of the activities. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the award recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the awardees for the project as a whole, although specific tasks and activities may be shared among the awardees and the NIH as defined below.
The PD(s)/PI(s) will have the primary responsibility for:
Awardees must actively seek, and as appropriate, form partnerships with other NIMHD grantees in their respective regions with expertise and/or interest in health policy or social determinants of health and other relevant resources that could be leveraged to facilitate achievement of TCC goals and objectives.
Awardees will retain custody of and have primary rights to the data and software developed under these awards, subject to Government rights of access consistent with current DHHS, PHS, and NIH policies.
NIH staff have substantial programmatic involvement that is above and beyond the normal stewardship role in awards. NIMHD will assign a Program Official and Project Scientist(s) to the TCC award. The Project Scientist(s) will have substantial scientific involvement during the conduct of this activity, through technical assistance, advice, and coordination. NIH Project Scientists(s) will:
An NIH Program Official will be responsible for the normal programmatic stewardship of the award and will be named in the award notice. The program official will:
Additionally, the NIH Program Official(s) may recommend the termination or curtailment of an activity in the event the proposed activities fail to evolve within the intent and purpose of this initiative.
Areas of Joint Responsibility include:
When multiple years are involved, awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
eRA Commons Help Desk (Questions regarding eRA Commons
registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
Michael Sayre, PhD
National Institute on Minority Health and Health Disparities (NIMHD)
Robert Nettey, MD
National Institute on Minority Health and Health Disparities (NIMHD)
Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health®
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.